(2S)-2-[[(1S)-1-carboxy-5-[[4-[[[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetyl]amino]methyl]benzoyl]amino]pentyl]carbamoylamino]pentanedioic acid

ID: ALA5279851

Max Phase: Preclinical

Molecular Formula: C36H54N8O15

Molecular Weight: 838.87

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(O)CC[C@H](NC(=O)N[C@@H](CCCCNC(=O)c1ccc(CNC(=O)CN2CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC2)cc1)C(=O)O)C(=O)O

Standard InChI:  InChI=1S/C36H54N8O15/c45-28(20-41-11-13-42(21-30(48)49)15-17-44(23-32(52)53)18-16-43(14-12-41)22-31(50)51)38-19-24-4-6-25(7-5-24)33(54)37-10-2-1-3-26(34(55)56)39-36(59)40-27(35(57)58)8-9-29(46)47/h4-7,26-27H,1-3,8-23H2,(H,37,54)(H,38,45)(H,46,47)(H,48,49)(H,50,51)(H,52,53)(H,55,56)(H,57,58)(H2,39,40,59)/t26-,27-/m0/s1

Standard InChI Key:  QGSSCKQGHNZORO-SVBPBHIXSA-N

Molfile:  

 
     RDKit          2D

 59 60  0  0  0  0  0  0  0  0999 V2000
   21.1372  -21.5372    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8517  -21.1247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4228  -21.1247    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.1372  -22.3622    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.5662  -21.5372    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.8517  -20.2998    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5662  -19.8873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5662  -19.0623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.2807  -18.6498    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.2807  -17.8248    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.2807  -21.1247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9952  -21.5372    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.2807  -20.2998    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.7096  -21.1247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4241  -21.5372    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7096  -20.2998    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4241  -19.8873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4241  -19.0623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1384  -18.6460    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.7095  -18.6460    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.4274  -22.3640    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.1420  -21.1265    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.0026  -17.4100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0079  -16.5838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7253  -16.1740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7305  -15.3478    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0146  -14.9294    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0220  -14.0995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7394  -13.6897    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.2973  -15.3391    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.2920  -16.1653    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7184  -17.8285    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.4644  -14.0834    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1678  -13.6523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4862  -14.9081    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.1462  -12.8275    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.8495  -12.3964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4210  -12.4339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3993  -11.6092    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.5745  -12.7900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.2780  -12.3588    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.2562  -11.5341    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.5311  -11.1406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.5095  -10.3158    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.1008  -11.1727    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.0736  -10.3481    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7740   -9.9123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.0030  -12.7523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.0247  -13.5770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.3232  -14.0107    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.7516  -13.9731    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.2138   -9.8863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9380  -10.2815    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9604  -11.1054    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.6449   -9.8511    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.4989  -10.6000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4741   -9.7754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1736   -9.3404    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.7453   -9.3833    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  2  6  1  6
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  5 11  1  0
 11 12  1  0
 11 13  2  0
 12 14  1  0
 14 15  1  0
 14 16  1  1
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  2  0
 15 21  1  0
 15 22  2  0
 10 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  1  0
 27 30  1  0
 30 31  2  0
 24 31  1  0
 23 32  2  0
 29 33  1  0
 33 34  1  0
 33 35  2  0
 34 36  1  0
 36 37  1  0
 36 38  1  0
 38 39  1  0
 37 40  1  0
 40 41  1  0
 41 42  1  0
 42 43  1  0
 43 44  1  0
 39 45  1  0
 45 46  1  0
 46 47  1  0
 47 44  1  0
 41 48  1  0
 48 49  1  0
 49 50  1  0
 49 51  2  0
 44 52  1  0
 52 53  1  0
 53 54  1  0
 53 55  2  0
 45 56  1  0
 56 57  1  0
 57 58  1  0
 57 59  2  0
M  END

Alternative Forms

  1. Parent:

    ALA5279851

    ---

Associated Targets(Human)

LNCaP (8286 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FOLH1 Tclin Glutamate carboxypeptidase II (711 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 838.87Molecular Weight (Monoisotopic): 838.3709AlogP: -2.25#Rotatable Bonds: 23
Polar Surface Area: 336.09Molecular Species: ZWITTERIONHBA: 13HBD: 10
#RO5 Violations: 3HBA (Lipinski): 23HBD (Lipinski): 10#RO5 Violations (Lipinski): 3
CX Acidic pKa: 1.25CX Basic pKa: 8.97CX LogP: -6.19CX LogD: -21.58
Aromatic Rings: 1Heavy Atoms: 59QED Weighted: 0.05Np Likeness Score: -0.56

References

1. Chia CSB..  (2023)  Novel PSMA-Targeting Radionuclide Peptidomimetics for Treating Prostate Cancer.,  14  (1.0): [PMID:36655127] [10.1021/acsmedchemlett.2c00510]
2. Benešová M, Bauder-Wüst U, Schäfer M, Klika KD, Mier W, Haberkorn U, Kopka K, Eder M..  (2016)  Linker Modification Strategies To Control the Prostate-Specific Membrane Antigen (PSMA)-Targeting and Pharmacokinetic Properties of DOTA-Conjugated PSMA Inhibitors.,  59  (5): [PMID:26878194] [10.1021/acs.jmedchem.5b01210]

Source